We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Inv Regulatory News (IIG)

Share Price Information for Intuitive Inv (IIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.00
Bid: 125.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 10.00 (8.00%)
Open: 130.00
High: 130.00
Low: 130.00
Prev. Close: 130.00
IIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sanondaf

26 May 2022 07:00

RNS Number : 8488M
Intuitive Investments Group plc
26 May 2022
 

 

26 May 2022

Intuitive Investments Group plc

Update on Sanondaf

Sanondaf awards new regional franchise and key appointments

Intuitive Investments Group plc, (AIM: IIG) ("IIG") announces the following update in respect of its largest single investment, Sanondaf.

 

Sanondaf awards new regional franchise

Sanondaf, a specialist disinfection and hygiene services business, has awarded a regional franchise in Kent, which covers the Discovery Science Park in Sandwich. The franchise will be headed by John Wamsley who runs a successful equipment supply and reconditioning business. He has an extensive knowledge of, and excellent relationships in, the life sciences sector.

This new regional franchise increases the number of regional franchises to 26, giving excellent and growing coverage throughout the United Kingdom. The award is in line with Sanondaf's targeted growth strategy in the life science sector. Sanondaf is a trusted partner of companies ranging from life science start-ups to multi-nationals. Customers include the NHS, research laboratories and pharmaceutical manufacturers.

Strengthening of the Sanondaf Team

Furthermore, Sanondaf announces three appointments.

Tom Hyland, Operations Director, has held senior positions in global life sciences companies including Johnson & Johnson Medical, Microsulis, Life Technologies and Alere Technologies. Tom started his career as a chemical engineer, has a chemistry degree and holds an MBA. Tom combines excellent technical engineering ability with exceptional managerial skills and will be responsible for operations and product development.

 

Collette McMorrow, Business Manager, has proven expertise in marketing, project management, business development and event management. Collette has held senior roles in leading companies such as Bayer and has a proven track record in digital system design, leadership, and performance management.

Helen McPike, Product Specialist, is a biosecurity specialist who has 20 years' experience in healthcare and has spent the last eight years working in the infection prevention and control sector. Helen has held senior sales roles and worked for the NHS, Byotrol and Fresnius and has first class honours science degree in Health Science. 

For further information, please contact:

 

Intuitive Investments Group plc

www.iigplc.com

Julian Baines, Non-Executive Chairman

Robert Naylor, CEO

Via Walbrook PR

 

SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0) 20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

 

Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope

 

Walbrook PR Limited - Media & Investor Relations

+44 (0)20 7933 8780 or intuitive@walbrookpr.com

Paul McManus/ Sam Allen

+44 (0) 7980 541 893 / +44 (0) 7502 558 258

 

About Sanondaf

Sanondaf provides specialist disinfection and hygiene services, primarily through its core technology of spraying and fogging. Sanondaf's decontamination service is based around a hydrogen peroxide formula, which is administered as a dry vapour disinfection treatment which can be used on all electrical and electronic devices and all hard and soft furnishings safely, without causing damage or leaving any unsightly residue on the surfaces treated. Treatments are non-corrosive, contain no toxic ingredients and Sanondaf's application methods ensure they are not harmful to people, animals or the environment. It is safe for use in all settings, including operating theatres, critical care units, and is CASA (Civil Aviation Safety Authority) approved. Sanondaf's disinfection formula has proven efficacy against pathogens, including, viruses such as Covid-19 and Monkeypox, mould, bacteria and fungi.

 

About Intuitive Investments Group plc

The Company is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPURCAUPPPGA
Date   Source Headline
8th Apr 20247:00 amRNSIssue and Allotment of Ordinary Shares
22nd Mar 20249:00 amRNSIIG celebrates Sir Nigel Rudd’s award win
21st Mar 20247:00 amRNSIssue and Allotment of Ordinary Shares
7th Mar 20247:00 amRNSHui10 contract win
29th Feb 202410:36 amRNSResult of AGM
28th Feb 20247:00 amRNSIssue of shares
27th Feb 20247:00 amRNSHui10 approved to expand with China Sports Lottery
16th Feb 20247:00 amRNSAppointment of Corporate Broker
6th Feb 202410:45 amRNSPosting of Annual Report and AGM Notice
1st Feb 20242:23 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSFinancial Results
4th Jan 20242:54 pmRNSIssue of shares
29th Dec 20237:00 amRNSTotal Voting Rights
12th Dec 20233:48 pmRNSIssue of shares
28th Nov 20237:00 amRNSUpdate to the Board of Directors
3rd Nov 20231:36 pmRNSDirector Dealing
1st Nov 202310:41 amRNSHolding(s) in Company
27th Oct 20231:33 pmRNSDirector Dealing
27th Oct 20237:00 amRNSInvestment in Hui10 Inc
31st Aug 20238:25 amRNSTotal Voting Rights
10th Aug 202311:08 amRNSHolding(s) in Company
8th Aug 20238:00 amRNSReadmission - Intuitive Investments Group plc
28th Jul 20233:35 pmRNSGM, Tender Offer & Placing & Directorate Change
13th Jul 20235:02 pmRNSForm 8.3 - Yourgene Health PLC - Correction
11th Jul 202310:47 amRNSNotice of General Meeting - Correction
11th Jul 20237:00 amRNSNotice of General Meeting to approve Proposals
11th Jul 20237:00 amRNSIIG appoints Sir Nigel Rudd as its next Chairman
5th Jul 20233:46 pmRNSFORM 8.3 - Yourgene Health Plc
29th Jun 20237:00 amRNSInterim report for the six months to 31 March 2023
31st May 20237:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSReorganisation and Deferred Consideration
26th Apr 20234:57 pmRNSHolding(s) in Company
17th Jan 202311:19 amRNSResult of AGM and Directorate Change
11th Jan 202310:00 amRNSInvestment in Yourgene Health plc
21st Dec 20227:00 amRNSFinal Results
7th Nov 20222:05 pmRNSSecond Price Monitoring Extn
7th Nov 20222:00 pmRNSPrice Monitoring Extension
5th Aug 20227:00 amRNSInvestment in PneumoWave Limited
26th May 20227:00 amRNSUpdate on Sanondaf
25th May 20227:00 amRNSHalf-year Report
20th Apr 202211:13 amRNSDispensation from Rule 9 of the Code
4th Apr 202211:13 amRNSTotal Voting Rights
8th Mar 20223:39 pmRNSHolding(s) in Company
2nd Mar 20227:00 amRNSSubscription
25th Feb 202212:11 pmRNSInvestment & Appointment of Non-Executive Chair
14th Feb 202212:59 pmRNSChange of Registered Office
14th Feb 20227:00 amRNSInvestment in Ocutec Limited
24th Jan 20228:45 amRNSDirector Dealing
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.